← Back to Search

Qi Gong for Cancer (QiGong Trial)

N/A
Waitlist Available
Research Sponsored by Arash Asher, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 11 weeks
Awards & highlights

QiGong Trial Summary

This trial will evaluate the feasibility and effectiveness of a QiGong program for treating chemotherapy-induced peripheral neuropathy in cancer patients.

Eligible Conditions
  • Cancer
  • Peripheral Neuropathy

QiGong Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~11 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 11 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Objective Modified Total Neuropathy Scale (mTNS) score
Subjective Neurotoxicity Subscale score
Secondary outcome measures
Attendance
Emotional Well-Being
Functional Well-Being
+7 more

QiGong Trial Design

1Treatment groups
Experimental Treatment
Group I: Qi GongExperimental Treatment1 Intervention
Weekly QiGong for Chemotherapy-Induced Neuropathy classes for 10 weeks

Find a Location

Who is running the clinical trial?

Arash Asher, MDLead Sponsor
3 Previous Clinical Trials
73 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025